arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DEXCOM INC

DXCM
$84.74 ▲ +1.75 (+2.11%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
87
Health
Excellent
Bullish
auto_awesome

Analytical Summary

DEXCOM INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $33.1B
Dividend Yield
Revenue Growth 15.6%
Op. Margin 19.6%
ROIC 25.5%
FCF / Share $2.76
Trailing P/E 39.6x
Price / Book 11.9x
FCF Yield 3.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.66B
↑ +15.6%
Net Income Profit after all expenses
$836.30M
↑ +45.1%
Operating Margin Operating profit as % of sales
19.6%
↑ +31.5% 74th
FCF / Share Free cash flow per share
$2.76
↑ +72.3%
Long-Term Debt Long-term obligations
$4.60M
↓ -32.4%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
80
Returns
93
Financial Health
94
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters